Takara Bio Inc.

Takara Bio Inc. is a global biotech firm delivering reagents, lab instruments and CDMO services across Japan, US, EU, and Asia. Its pipeline features gene therapies including NY-ESO-1 siTCR, oncolytic HSV, CAR‑T, and platforms like RetroNectin and CereAAV.

Headquarters: Japan (JPN)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Professional Services
Industry: Biotechnology Research

Employees: 1,779
HQ: Kusatsu

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
4974	Takara Bio Inc. Cap: 100.4B	EQUITY	JPX	JPY	JP3460200003	Active	📈